logo
logo

Mark Lovern Joins In Silico Trials As Chief Platform Officer

Oct 17, 2023over 1 year ago

Position

Chief Platform Officer

Company

InSilicoTrials

Mark Lovern
WilmingtonIT Services and IT Consulting

Description

Today, InSilicoTrials warmly welcomes Dr. Mark Lovern in his new role as Chief Platform Officer, a move marking the company's continued commitment to leading the frontier of AI-driven innovation and simulation in life sciences.

Company Information

Company

InSilicoTrials

Location

Wilmington, Delaware, United States

About

We are a game-changer in the life sciences sector. Our mission is to hyper-accelerate drug and medical device development leveraging top notch technology like Modeling and Simulation and Artificial Intelligence. We are an international team of professionals ​coming from healthcare, regulatory, engineering simulation, IT, cloud, and cybersecurity. We work with a network of 70+ prestigious universities and research centers worldwide and we are currently part of 5 EU-funded projects that are really making a difference in healthcare: SimCardioTest, Brainteaser, In Silico World, Disc4All and TranSys. Our unique cloud platform offers Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of medical products development, while increasing their safety and efficacy. We are endorsed by top international regulators such as FDA and EMA., that have been encouraging for years the adoption of in silico methods in healthcare.

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Related People

Mark hidden

hidden

Dr. hidden